Related Experiment Video
Updated: May 25, 2026
08:53
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Time for a neurorestorative therapy in stroke.
Expert Opinion on Biological Therapy
|January 19, 2012
Summary
Stroke pharmacotherapy research faces challenges, with many drugs failing clinical trials. Trafermin, a basic fibroblast growth factor, shows promise for neuronal restoration, not just acute neuroprotection, in stroke recovery.
Area of Science:
- Neuroscience
- Pharmacology
- Biomedical Research
Background:
- Stroke is a leading cause of death and disability, with an increasing burden due to population aging.
- Despite significant investment, few pharmacotherapies beyond recombinant tissue plasminogen activator (rtPA) have succeeded for ischemic stroke.
- Many pharmaceutical companies have reduced stroke research programs, leading to a slowdown in the field.
Discussion:
- Trafermin, a recombinant basic fibroblast growth factor (bFGF), represents a translational failure in neuroprotection for stroke.
- However, bFGF may possess neurorestorative properties, promoting neuronal plasticity following cerebral insults.
- This suggests a potential shift in therapeutic strategy for stroke treatment.
Key Insights:
- Experimental stroke therapies often fail in clinical translation, highlighting the complexity of neuroprotection.
- Trafermin's potential lies in promoting neuronal repair and plasticity rather than immediate neuroprotection.
- The focus for future clinical trials with trafermin should be on long-term recovery and restoration.
Outlook:
- Future clinical trials for trafermin in stroke should prioritize neuronal restoration and plasticity.
- Re-evaluating therapeutic targets may overcome past translational failures in stroke pharmacotherapy.
- Further research into bFGF's role in neurogenesis and synaptic repair is warranted.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...